ENDRA Life Sciences Inc. NDRA
6.04
0.11
1.85%
as of 25 Sep
- Market cap
- $8.9M
- P/E
- 0.0×
Follow NDRA
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.99 | 1.02 | 0.43 | 7.04 | |
Current Ratio |
1.31 | 1.29 | 0.64 | 7.10 | |
Net Debt/EBITDA |
0.60 | 0.48 | 0.17 | 3.84 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.73 | 0.51 | 0.85 | (5.80) | |
Capex/Depreciation |
0.00 | (75.95) | 0.00 | (0.48) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.53) | (2.05) | (0.93) | (0.70) | |
Capex per Share |
0.00 | (3.81) | 0.00 | (0.01) | |
Free Cash Flow per Share |
(1.53) | (5.86) | (0.93) | (0.71) | |
Cash per Share |
1.04 | 0.97 | 0.30 | 4.18 | |
Shareholders Equity per Share |
0.23 | 2.87 | 1.49 | 4.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.23 | 2.87 | 1.49 | 4.77 | |
Free Cash Flow |
(1.16) | (4.61) | (1.12) | (0.95) | |
Working Capital |
0.25 | 0.22 | (0.30) | 4.80 | |
Capital Expenditures |
0.00 | (3.00) | — | (0.02) | |
Net Current Asset Value |
(0.74) | (0.63) | (1.11) | 3.95 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
0.65 | 0.56 | 0.57 | 0.55 | |
Average Assets |
5.17 | 4.15 | 3.30 | 5.37 | |
Average Common Equity |
3.39 | 2.41 | 1.77 | 3.89 |
Columns are period end dates